Analysts Hike Targets on Amex, Coinbase

Analyst consensus target prices shifted upward on several names Friday, with two financial heavyweights leading the moves.

AXP drew the largest target bump in absolute terms. The average analyst price target rose to $369.52, up from $369.44, following post-earnings revisions. Fifteen analysts hold buy ratings on the stock, with none at sell.

COIN also attracted upward target revisions. The consensus price target moved to $213.55 from $212.31. Crypto markets remain elevated, supporting bullish sentiment on the exchange operator.

DECK saw multiple rating changes at once. Its consensus target fell sharply to $99.95 from $115.48, a drop of more than 13%. Three analysts now carry sell ratings, up from four previously. The footwear maker has struggled with slowing Hoka momentum.

BSX suffered a small target trim. Boston Scientific's consensus target edged down to $57.82 from $58.00. The medical device sector has faced margin pressure from elevated input costs.

On the macro side, Taiwan's export orders hit a record high in September, reaching NT$3,622.3bn, the largest September reading since 1984. That backdrop may support continued positive sentiment toward tech supply chain names. CTSH saw its consensus target lifted to $67.10 from $66.66, as IT services firms benefit from rising enterprise tech spend.

SLB lost a recommendation entirely from the consensus panel, though the average target held near $62.34.